AOD-9604 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
AOD-9604 is being researched for weight loss applications. Activates beta-3 adrenergic receptors in adipose tissue, triggering cAMP-mediated lipolysis and release of stored fat for energy. Suppresses lipogenesis (new fat formation) while promoting fat breakdo. Common dosages for this use range from 250-1000 mcg daily once daily, ideally morning fasted.
Can AOD-9604 Help With Weight Loss?
AOD-9604 (Fragment 177-191 of Human Growth Hormone (modified)) is being researched for weight loss applications based on its mechanism as a Lipolytic peptide, GH fragment analog.
Activates beta-3 adrenergic receptors in adipose tissue, triggering cAMP-mediated lipolysis and release of stored fat for energy. Suppresses lipogenesis (new fat formation) while promoting fat breakdown. Unlike full growth hormone, it does not raise IGF-1 or impact glucose metabolism, blood sugar, or insulin sensitivity.
What Does the Research Show for AOD-9604 and Weight Loss?
12-week RCT showed 2.6 kg weight loss vs 0.8 kg placebo. However, a larger 24-week Phase III trial (536 subjects) failed to demonstrate significant weight loss, leading to development discontinuation in 2007. Six controlled trials established tolerability across 900+ subjects.
The relevance to weight loss specifically comes from AOD-9604's effects on fat loss, increased fat oxidation, improved body composition, joint health support, no IGF-1 elevation.
What Protocol Is Used for Weight Loss?
For weight loss applications, the standard AOD-9604 protocol is 250-1000 mcg daily administered once daily, ideally morning fasted via subcutaneous injection for 12-24 weeks.
Some researchers adjust dosing based on the specific weight loss application — see our AOD-9604 dosage guide for full protocol details.
Can Stacking Improve Weight Loss Results?
Pairs with CJC-1295/Ipamorelin for enhanced body composition (AOD handles fat loss while GH peptides handle lean mass). Also complements fasting and HIIT training protocols.
What Side Effects Apply to Weight Loss Use?
Well-tolerated across 900+ participants in clinical trials. Minimal adverse effects — potential mild headache, dizziness, or injection site reactions. One of the safest peptides in terms of documented human tolerability.
Side effects are generally consistent regardless of the specific application. See our AOD-9604 side effects guide for details.
Calculate Your AOD-9604 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for AOD-9604.
Open Calculator →Bottom Line: AOD-9604 for Weight Loss
AOD-9604 shows preliminary research potential for weight loss. Standard protocols (250-1000 mcg daily, once daily, ideally morning fasted, 12-24 weeks) apply.
Source from COA-tested vendors and maintain consistent dosing for the full cycle duration.
Complete Guide
AOD-9604: The Fat Loss Peptide Fragment
Related Reading
- AOD-9604 Dosage Guide
- AOD-9604 Benefits
- AOD-9604 Side Effects
- AOD-9604 Stacking Guide
- AOD-9604 Cycle Guide
- AOD-9604 Research
Research-Grade Sourcing
If you're going to research AOD-9604, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is AOD-9604?
AOD-9604 (Fragment 177-191 of Human Growth Hormone (modified)) is a Lipolytic peptide, GH fragment analog. Synthetic analog of human GH fragment 177-191, engineered to selectively activate lipolysis without systemic GH effects. It is researched for fat loss, increased fat oxidation, improved body composition, joint health support, no IGF-1 elevation.
What is the recommended AOD-9604 dosage?
Common dosages: 250-1000 mcg daily administered once daily, ideally morning fasted via subcutaneous injection. Cycle length: 12-24 weeks. Half-life: not established. Use our peptide calculator for exact reconstitution math.
What are the side effects of AOD-9604?
Well-tolerated across 900+ participants in clinical trials. Minimal adverse effects — potential mild headache, dizziness, or injection site reactions. One of the safest peptides in terms of documented human tolerability.
Is AOD-9604 safe?
AOD-9604 has shown a favorable safety profile in research. Not FDA-approved. Development discontinued 2007. Available as research chemical. All research should follow appropriate safety protocols.